Subscribe To
Tyra biosciences: early stage developer of novel fgfr3-selective molecules
TYRA has the first FGFR3 inhibitor in the clinic. The company has a large market cap for an early-stage...
June 1, 2023, 5:25 am
C4x discovery overcomes side-effect seen in competitor cancer drugs
C4X Discovery Holdings PLC (AIM:C4XD) has successfully completed a crucial preclinical study showing its MALT-1 inhi...
June 1, 2023, 2:49 am
Effector therapeutics announces closing of $7.5 million registered direct offering priced at-the-market under nasdaq rules
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 31, 2023 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the developme...
May 31, 2023, 9:43 pm
Pfizer (pfe) posts upbeat data from hemophilia drug study
Data from a late-stage study shows that treatment with Pfizer's (PFE) experimental anti-TFPI inhibitor ...
May 31, 2023, 1:16 pm
Healthcare triangle to participate in 2023 muse inspire conference as exhibitor and host of best practice sessions
Company’s “tech talks” and focus group will address methodologies supporting the highest standards for data protection and information security ...
May 31, 2023, 12:36 pm
Fmls 23: join the global elite
Finance Magnates London Summit (FMLS) has emerged as a premier event in the financial industry. Held on November 20-22 at Old Billingsgate, the bigges...
May 30, 2023, 7:48 am
Biomea: novel approach to diabetes and cancer
BMEA develops oral covalent small molecules for cancer and diabetes. Its lead asset is a menin inhibito...
May 28, 2023, 7:57 am
Unusual call option trade in proshares trust – proshares bitcoin strategy etf (bito) worth $570.00k
ET an unusually large $570.00K block of Call contracts in ProShares Trust – ProShares Bitcoin Strategy ETF (...
May 27, 2023, 3:29 am
Roche, with ocrevus and fenebrutinib advancement, should be top ms contender
It is expected that the market opportunity for disease-modifying therapies for MS will reach $29.8 billion in 2030; further projected that OCREVUS cou...
May 25, 2023, 7:36 pm
Cullinan oncology to present first monotherapy clinical data for cln-619, a novel anti-mica/b antibody, at asco 2023
CLN-619 demonstrated monotherapy activity across a range of tumor types, including in patients whose cancer had progressed on checkpoint inhi...
May 25, 2023, 5:00 pm
Exhibitors and sponsors flock to prismhr live 2023, this year’s premier event for hr service providers
Located in The Live Music Capital of the World, Upcoming Conference Will Connect Industry’s Most Prominent Leaders HOPKINTON, Mass., May 23, 2023 (G...
May 23, 2023, 11:00 am
Kalvista pharmaceuticals to present at stifel 2023 tailoring genes: genetic medicines day virtual conference
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
May 23, 2023, 6:30 am
Reviva pharmaceuticals announces presentation of clinical pharmacology studies data on brilaroxazine at the aspet 2023 annual meeting
Data reinforce brilaroxazine’s differentiated clinical pharmacology and safety profile Brilaroxazine may be co-administered with other drugs metabol...
May 22, 2023, 10:30 am
Abbvie's (abbv) rinvoq gets fda nod to treat crohn's disease
AbbVie (ABBV) announces the seventh FDA approval of its JAK inhibitor, Rinvoq, for the treatment of adu...
May 19, 2023, 11:28 am
Regeneron applauds supreme court’s unanimous opinion striking down amgen’s pcsk9 patent claims and supporting scientific innovation
Decision ends nearly decade-long patent dispute related to Regeneron-invented Praluent® (alirocumab) TARRYTOWN, N.Y., May 18, 2023 (GLOBE NEWSWIRE) �...
May 18, 2023, 3:45 pm
Fmls23 returns this november in its largest installment yet
The Finance Magnates London Summit (FMLS), arguably the largest and most anticipated event of 2023, will be returning for its 11th year this November....
May 18, 2023, 1:32 pm
Drone nerds will feature industry thought leaders as speakers for elevateuav summit
The ElevateUAV Summit in Miami will feature experts from various industries, including Public Safety, Construction, and more! Dania Beach, FL, May 17,...
May 17, 2023, 10:20 pm
Bayer's (bayry) arrhythmia prevention drug gets fast track tag
Bayer's (BAYRY) oral FXIa inhibitor, asundexian, gets the FDA's Fast Track Designation, as a preventive...
May 17, 2023, 12:47 pm
Immunic notes neuroprotective potential of vidofludimus calcium highlighted in preclinical data
Immunic Inc (NASDAQ:IMUX) has announced the publication of preclinical data highlighting the neuroprotective potential of its investigational drug, v...
May 17, 2023, 8:21 am
Vislink leverages growth opportunities in the middle east as a featured exhibitor at cabsat 2023
The Company Will Showcase its Portfolio of AI, 5G and Cloud-based REMI Solutions for Live Sports and Broadcasting Dubai, UAE, May 16, 2023 (GLOBE NEWS...
May 16, 2023, 4:05 am